We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$252B
AUM Growth
-$7.74B
Cap. Flow
-$3.59B
Cap. Flow %
-1.43%
Top 10 Hldgs %
22.68%
Holding
10,737
New
1,370
Increased
3,710
Reduced
4,352
Closed
1,178

Sector Composition

Rank Sector Weight
1 Miscellaneous 87.56%
2 Technology 2.53%
3 Consumer Discretionary 2.02%
4 Financials 1.63%
5 Healthcare 1.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSM icon
9301
PUT
Fortuna Silver Mines
FSM
$3.79B
$57K ﹤0.01%
12,500
-12,700
-50% -$54.4K
ORMP icon
9302
Oramed Pharmaceuticals
ORMP
$214M
$57K ﹤0.01%
12,468
+2,329
+23% +$15.3K
PALI icon
9303
CALL
Palisade Bio
PALI
$368M
0
ACW
9304
DELISTED
Accuride Corp
ACW
$57K ﹤0.01%
+13,139
New +$59.2K
PCO
9305
DELISTED
Pendrell Corporation - Class A
PCO
$57K ﹤0.01%
41
+23
+128% +$32.3K
SVA
9306
DELISTED
Sinovac Biotech, Ltd
SVA
$57K ﹤0.01%
10,897
-4,544
-29% -$23.2K
XXII
9307
22nd Century Group
XXII
$2.2M
0
ACGN
9308
PUT
DELISTED
Aceragen Inc
ACGN
$56K ﹤0.01%
93
-1,592
-94% -$638K
CASC
9309
CALL
DELISTED
Cascadian Therapeutics, Inc.
CASC
$56K ﹤0.01%
4,883
-35,000
-88% -$380K
VMEM
9310
CALL
DELISTED
VIOLIN MEMORY, INC.
VMEM
$56K ﹤0.01%
+2,925
New +$55.5K
DRD
9311
DRDGold
DRD
$2.6B
$55K ﹤0.01%
+35,071
New +$83.7K
BXE
9312
CALL
DELISTED
Bellatrix Exploration Ltd.
BXE
$55K ﹤0.01%
+3,040
New +$67.6K
WRES
9313
CALL
DELISTED
WARREN RESOURCES INC
WRES
$54K ﹤0.01%
33,700
-31,100
-48% -$88.1K
DZSI
9314
DELISTED
DZS Inc. Common Stock
DZSI
$53K ﹤0.01%
5,965
-6,468
-52% -$69.7K
HIVE
9315
PUT
DELISTED
Aerohive Networks
HIVE
$53K ﹤0.01%
+11,100
New +$57.2K
RLOC
9316
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$53K ﹤0.01%
+15,344
New +$56.4K
ALXA
9317
DELISTED
Alexza Pharmaceuticals Inc
ALXA
$53K ﹤0.01%
35,258
+2,262
+7% +$4.04K
OIBR.C
9318
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$53K ﹤0.01%
3,176
+3,147
+10,852% +$803K
NSU
9319
DELISTED
Nevsun Resources Ltd.
NSU
$53K ﹤0.01%
+13,514
New +$49.3K
AXIA
9320
DELISTED
AXIA Energia
AXIA
$52K ﹤0.01%
30,907
+15,249
+97% +$28.7K
ALXA
9321
PUT
DELISTED
Alexza Pharmaceuticals Inc
ALXA
$52K ﹤0.01%
35,000
-11,500
-25% -$20.5K
GTI
9322
CALL
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
$51K ﹤0.01%
10,000
-150,900
-94% -$662K
RCPI
9323
PUT
DELISTED
ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
$51K ﹤0.01%
11,128
-620
-5% -$3.26K
RSOL
9324
DELISTED
REAL GOODS SOLAR, INC. CL A COM
RSOL
$51K ﹤0.01%
106,676
+42,457
+66% +$20.3K
ORMP icon
9325
CALL
Oramed Pharmaceuticals
ORMP
$214M
$50K ﹤0.01%
+11,000
New +$72.3K

Similar funds

Jeff Yass's Q4 2014 Portfolio in Review

As of Q4 2014, Jeff Yass held 10,737 positions worth $252B, down 3% from $260B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jeff Yass's Q4 2014 filing shows 1,370 new, 3,710 increased, 4,352 reduced and 1,178 closed positions. Its largest new stake was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $1.37B.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, up from 87% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2014 buy was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.22B increase.
  • Jeff Yass's biggest Q4 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.37B.
  • Jeff Yass fully exited Bausch Health in Q4 2014, selling an estimated $68.9M.
  • Jeff Yass's ten largest holdings make up 23% of its $252B portfolio in Q4 2014.
  • Jeff Yass opened 1,370 new positions and closed 1,178 in Q4 2014.
  • Jeff Yass's portfolio value fell 3% quarter-over-quarter to $252B.

Based on Susquehanna International Group's 13F filing for Q4 2014, filed 17 Feb 2015.